Bacterial Nanocellulose and Titania Hybrids: Cytocompatible and Cryopreservable Cell Carriers
20 October 2020

Irene Anton-Sales, Soledad Roig-Sanchez, María Jesús Sánchez-Guisado, María Jesús Sánchez-Guisado, Anna Laromaine*, and Anna Roig*. ACS Biomater. Sci. Eng. 2020, 6, 9, 4893–4902. Publication Date:August 11, 2020.

Carrier-assisted cell transplantation offers new strategies to improve the clinical outcomes of cellular therapies. Bacterial nanocellulose (BC) is an emerging biopolymer that might be of great value in the development of animal-free, customizable, and temperature-stable novel cell carriers. Moreover, BC exhibits a myriad of modification possibilities to incorporate additional functionalities. Here, we have synthesized BC-titanium dioxide (TiO2) nanocomposites (BC/TiO2) to evaluate and compare the suitability of not only BC but also a model hybrid nanobiomaterial as cell transplantation supports. This work provides thorough information on the interactions between BC-based substrates and model human cells in terms of cell attachment, morphology, proliferation rate, and metabolic activity. Two methods to partially retrieve the adhered cells are also reported. Both BC and BC/TiO2 substrates are positively evaluated in terms of cytocompatibility and endotoxin content without detecting major differences between BC and BC nanocomposites. Lastly, the effective cryopreservation of cells-BC and cells-BC/TiO2 constructs, yielding high cell viability and intact cell carrier's characteristics after thawing, is demonstrated. Taken together, our results show that both BC and BC/TiO2 enable to integrate the processes of expansion and long-term storage of human cells in transportable, robust and easy to manipulate supports.

Bacterial Nanocellulose and Titania Hybrids: Cytocompatible and Cryopreservable Cell Carriers

Hits: 1077
Bioactive materials for therapy and diagnosis

Bacterial Nanocellulose and Titania Hybrids: Cytocompatible and Cryopreservable Cell Carriers

Also at ICMAB

  • Cobaltabis(dicarbollide) ([o-COSAN]−) as Multifunctional Chemotherapeutics: A Prospective Application in Boron Neutron Capture Therapy (BNCT) for Glioblastoma

    25 January 2022 271 hit(s) Biomaterials
    Purpose: The aim of our study was to assess if the sodium salt of cobaltabis(dicarbollide) and its di-iodinated derivative (Na[o-COSAN] and Na[8,8′-I2-o-COSAN]) could be promising agents for dual anti-cancer treatment (chemotherapy + BNCT) for GBM. Methods: The biological activities of the small molecules were evaluated in vitro with glioblastoma cells lines U87 and T98G in 2D and 3D cell models and in vivo in the small model animal Caenorhabditis elegans (C. elegans) at the L4-stage and using the eggs. Results: Our studies indicated that only spheroids from the U87 cell line have impaired growth after treatment with both compounds, suggesting an increased resistance from T98G spheroids, contrary to what was observed in the monolayer culture, which highlights the need to employ 3D models for future GBM studies.
  • Ultrafast Interface Charge Separation in Carbon Nanodot–Nanotube Hybrids

    18 January 2022 273 hit(s) Biomaterials
    Carbon dots are an emerging family of zero-dimensional nanocarbons behaving as tunable light harvesters and photoactivated charge donors. Coupling them to carbon nanotubes, which are well-known electron acceptors with excellent charge transport capabilities, is very promising for several applications.
  • Polylactide, Processed by a Foaming Method Using Compressed Freon R134a, for Tissue Engineering

    17 December 2021 276 hit(s) Biomaterials
    Fabricating polymeric scaffolds using cost-effective manufacturing processes is still challenging. Gas foaming techniques using supercritical carbon dioxide (scCO2) have attracted attention for producing synthetic polymer matrices; however, the high-pressure requirements are often a technological barrier for its widespread use. Compressed 1,1,1,2-tetrafluoroethane, known as Freon R134a, offers advantages over CO2 in manufacturing processes in terms of lower pressure and temperature conditions and the use of low-cost equipment.
  • Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke

    07 December 2021 425 hit(s) Biomaterials
    The increasing use of mechanical thrombectomy in stroke management has opened the window to local intraarterial brain delivery of therapeutic agents. In this context, the use of nanomedicine could further improve the delivery of new treatments for specific brain targeting, tracking and guidance. In this study we take advantage of this new endovascular approach to deliver biocompatible poly(D-L-lactic-co-glycolic acid) (PLGA) nanocapsules functionalized with superparamagnetic iron oxide nanoparticles and Cy7.5 for magnetic targeting, magnetic resonance and fluorescent molecular imaging.
  • Synchrotron-Based Fourier-Transform Infrared Micro-Spectroscopy (SR-FTIRM) Fingerprint of the Small Anionic Molecule Cobaltabis (dicarbollide) Uptake in Glioma Stem Cells

    09 November 2021 340 hit(s) Biomaterials
    The anionic cobaltabis (dicarbollide) [3,3′-Co(1,2-C2B9H11)2]−, [o-COSAN]−, is the most studied icosahedral metallacarborane. The sodium salts of [o-COSAN]− could be an ideal candidate for the anti-cancer treatment Boron Neutron Capture Therapy (BNCT) as it possesses the ability to readily cross biological membranes thereby producing cell cycle arrest in cancer cells.   BNCT is a cancer therapy based on the potential of 10B atoms to produce α particles that cross tissues in which the 10B is accumulated without damaging the surrounding healthy tissues, after being irradiated with low energy thermal neutrons.

INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA, Copyright © 2020 ICMAB-CSIC | Privacy Policy | This email address is being protected from spambots. You need JavaScript enabled to view it.